Close Navigation
About ArixStrategy
OverviewInvestment caseNewsResultsDocumentsEventsCalendarAnalystsStock infoContact
AboutStrategyTeamPortfolioInsightsMediaContact
Investors
AboutStrategyTeamPortfolioInsightsMediaContact
Investors
OverlayOverlay
Artios logo

Find out more →

OverlayOverlay
Aura logo

Find out more →

INVESTING IN LIFE CHANGING SCIENCE

Discover more

Our Portfolio

With a focus on late pre-clinical to clinical stage ventures and covering a diversified range of therapeutic areas, we partner with the most ambitious scientists and entrepreneurs to build companies around game-changing life science innovation.

View full portfolio
Video
Video

Team

Experienced and collaborative team, with deep industry and scientific expertise.

Meet the team

Angela Ené

Interim Finance Director

Michelle Brandt

Executive Assistant

Laura Craig

Team & Marketing Coordinator

Felix Breyer, PhD

Associate

Mark Chin

Managing Director

Emmanuel Lacroix, PhD

Venture Partner

Robert Lyne

CEO

Mesh

Investors

Public market access to revolutionary medical innovation.

Find the latest share price, presentations, events and regulatory announcements here.

Visit Investor Centre
Share price

Latest News

Updates from Arix and our porfolio companies.

Read more news

Portfolio Company

20th January 2023

Disc Medicine Announces Exclusive Licensing Agreement with Mabwell Therapeutics for Novel Anti-TMPRSS6 Monoclonal Antibodies to Modulate Iron Homeostasis

Arix

5th January 2023

Twelve Bio to be acquired alongside $85 million financing of Ensoma co-led by Arix to create best-in-class engineered cell therapy platform

Portfolio Company

5th January 2023

Ensoma Announces $85 Million Financing and Agreement to Acquire Twelve Bio to Advance Portfolio of In Vivo Engineered Cellular Medicines

Arix

30th December 2022

Portfolio Company Disc Medicine Completes Merger with Gemini Therapeutics

Arix Bioscience

About Arix

The Team

Portfolio

Insights

News & Events

Contact

Investor Relations

Results Centre

Financial Calendar

Regulatory News

Document Library

Analysts & Advisors

Shareholder Information

Meta

Privacy Policy

Terms of use

Cookie Policy

Stay up to date

Sign up to receive regulatory news and results

Subscribe
Arix Bioscience
linkedintwitter

Arix Bioscience plc, registered in England and Wales with company number 09777975

Registered office: Duke Street House, 50 Duke Street, London, W1K 6JL, United Kingdom

Website by Ether